Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

A nonsurgical technique for blood access in extracorporeal affinity adsorption of antibodies in rats.

Författare

Summary, in English

Monoclonal antibodies for targeting cytotoxic conjugates to tumor cells are currently being evaluated together with extracorporeal affinity adsorption. The aim of the adsorption was to reduce undesired side effects in normal organs and to increase the tumor-to-normal tissue ratios. This technique is also applicable to several other therapeutic areas such as immune-mediated disorders, that is, autoimmunity, allergy, and transplantation rejection. We describe an improved technique for extracorporeal affinity adsorption of radiolabeled biotinylated antibodies in rats. Blood access is established through the tail artery and tail vein, without surgical insertion of permanent catheters. This technique is simple, does not require surgery, and causes only minimal stress to the animals. In addition, experiments can be carried out on several animals simultaneously. This new technique is of considerable benefit for studying extracorporeal affinity adsorption in rats, as experiments can be carried out with negligible anatomical and physiological interventions, compared to previously used techniques.

Publiceringsår

2007

Språk

Engelska

Sidor

312-316

Publikation/Tidskrift/Serie

Artificial Organs

Volym

31

Issue

4

Dokumenttyp

Artikel i tidskrift

Förlag

Wiley-Blackwell

Ämne

  • Surgery
  • Radiology, Nuclear Medicine and Medical Imaging
  • Cancer and Oncology
  • Neurology

Nyckelord

  • adsorption
  • radioimmunotherapy
  • affinity
  • blood access
  • extracorporeal
  • rat
  • avidin-biotin system
  • immunotargeting
  • immune-mediated disorders

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 0160-564X